NeuroVive Pharmaceutical AB clinical trials
Acquired by Pharming Group N.V., Feb 7, 2025 · source ↗
The registry lists 2 studies whose lead sponsor is NeuroVive Pharmaceutical AB. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 4, 2017.
Before and after it joined Pharming Group N.V.
- First submitted before NeuroVive Pharmaceutical AB became part of Pharming Group N.V.
- 2
- First submitted after NeuroVive Pharmaceutical AB became part of Pharming Group N.V.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- NeuroVive Pharmaceutical AB2 studies
Something wrong with this grouping? Tell us on the Pharming Group N.V. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Pharming Group N.V. studies →
- Copenhagen Head Injury Ciclosporin (CHIC) StudyCompletedNCT01825044Phase 2
Sponsor listed in the registry: NeuroVive Pharmaceutical AB · First submitted before NeuroVive Pharmaceutical AB became part of Pharming Group N.V.
- A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy VolunteersCompletedNCT01692834Phase 1
Sponsor listed in the registry: NeuroVive Pharmaceutical AB · First submitted before NeuroVive Pharmaceutical AB became part of Pharming Group N.V.